Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Revvity, Inc. Common Stock (NY:RVTY)

92.97 UNCHANGED
Streaming Delayed Price Updated: 7:00 PM EST, Nov 3, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Revvity, Inc. Common Stock

< Previous 1 2 3 4 5 6 7 8 Next >
Tesla, AMD, SMCI, Nike, Revvity: Stocks Making The Biggest Moves Today
Tesla’s shares continued to rise on Monday, extending the surge from Friday after the company announced a $16.5 billion partnership with Samsung Electronics for semiconductor chips. 
Via Stocktwits
Topics ETFs Government World Trade
Discover which S&P500 stocks are making waves on Monday.
Wondering what's happening in today's session for the S&P500 index? Stay informed with the top movers within the S&P500 index on Monday. 
Via Chartmill
Revvity Slashes Outlook As China Policy Deals Diagnostics Blow
Revvity beat Q2 earnings estimates but cut its 2025 profit outlook as China policy changes hit its immunodiagnostics business. 
Via Benzinga
Gapping S&P500 stocks in Monday's session
Monday's session is showcasing interesting market movements in the S&P500 index, with notable gap up and gap down stocks. Stay updated with the gapping S&P500 stocks in today's session. 
Via Chartmill
A Glimpse of Revvity's Earnings Potential
 
Via Benzinga
Peering Into Revvity's Recent Short Interest
 
Via Benzinga
Is the Market Bullish or Bearish on Revvity?
 
Via Benzinga
ATAI Life Sciences, Revvity And Other Big Stocks Moving Lower In Monday's Pre-Market Session
 
Via Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
 
Via Benzinga
Revvity Q2 Revenue Up 4 Percent
Via The Motley Fool
Topics Economy
Revvity (NYSE:RVTY) Surprises With Q2 Sales
Life sciences company Revvity (NYSE:RVTY) beat Wall Street’s revenue expectations in Q2 CY2025, with sales up 4.1% year on year to $720.3 million. The company expects the full year’s revenue to be... 
Via StockStory
Revvity Announces Financial Results for the Second Quarter of 2025
From Revvity
Via Business Wire
Earnings Scheduled For July 28, 2025
 
Via Benzinga
What To Expect From Revvity’s (RVTY) Q2 Earnings
Life sciences company Revvity (NYSE:RVTY) will be reporting results this Monday morning. Here’s what you need to know. 
Via StockStory
Topics Artificial Intelligence
Revvity Board Declares Quarterly Dividend
From Revvity
Via Business Wire
Monday's session: gap up and gap down stock in the S&P500 index
Wondering what's happening in today's session regarding gap up and gap down stocks? Explore the S&P500 index on Monday to uncover the stocks that are gapping in the S&P500 index. 
Via Chartmill
Thermo Fisher, Exact Sciences, Integer Holdings, Revvity, and 10x Genomics Shares Are Falling, What You Need To Know
A number of healthcare stocks fell in the afternoon session after several negative developments weighed on the sector. Weakness in managed care providers was a significant factor, with companies like... 
Via StockStory
Topics Lawsuit World Trade
Reflecting On Research Tools & Consumables Stocks’ Q1 Earnings: Revvity (NYSE:RVTY)
Let’s dig into the relative performance of Revvity (NYSE:RVTY) and its peers as we unravel the now-completed Q1 research tools & consumables earnings season. 
Via StockStory
Topics Economy
Revvity to Hold Earnings Call on Monday, July 28, 2025
From Revvity
Via Business Wire
3 Low-Volatility Stocks in the Doghouse
Stability is great, but low-volatility stocks may struggle to deliver market-beating returns over time as they sometimes underperform during bull markets. 
Via StockStory
What 9 Analyst Ratings Have To Say About Revvity
 
Via Benzinga
1 Profitable Stock with Exciting Potential and 2 to Be Wary Of
Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a business is in the green today doesn’t mean it will thrive tomorrow. 
Via StockStory
3 Healthcare Stocks Skating on Thin Ice
From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. But speed bumps such as inventory destockings have persisted in the wake of... 
Via StockStory
Topics Stocks
Revvity Introduces New IVD Reference Standards for Monitoring Oncology Diagnostic Testing Workflows
From Revvity
Via Business Wire
Revvity’s EUROIMMUN Unveils New Fully Automated Instrument for Specialty Testing
From Revvity
Via Business Wire
3 Mid-Cap Stocks with Questionable Fundamentals
Many investors pay attention to mid-cap stocks because they have established business models and expansive market opportunities. However, their paths to becoming $100 billion corporations are ripe with... 
Via StockStory
Stay informed with the top movers within the S&P500 index on Wednesday.
Join us in exploring the top gainers and losers within the S&P500 index one hour before the close of the markets on Wednesday as we examine the latest happenings in today's session. 
Via Chartmill
What's going on in today's session: S&P500 movers
Curious about the top performers within the S&P500 index in the middle of the day on Wednesday? Dive into the list of today's session's top gainers and losers for a comprehensive overview. 
Via Chartmill
Which S&P500 stocks are gapping on Wednesday?
Looking for the S&P500 stocks that are experiencing notable gaps on Wednesday? Find out which stocks are gapping up and gapping down in the S&P500 index during today's session. 
Via Chartmill
Repligen, Bruker, Agilent, Medpace, and Revvity Shares Skyrocket, What You Need To Know
A number of stocks jumped in the afternoon session after the major indices popped (Nasdaq +3.4%, S&P 500 +2.5%) in response to the positive outcome of U.S.-China trade negotiations, as both sides... 
Via StockStory
Topics Government Stocks World Trade
< Previous 1 2 3 4 5 6 7 8 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.